Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Chubb
US Department of Justice
Teva
Colorcon
UBS
Deloitte
QuintilesIMS
Fish and Richardson

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070070

« Back to Dashboard

NDA 070070 describes METHYLDOPA, which is a drug marketed by Accord Hlthcare, Duramed Pharms Barr, Halsey, Ivax Sub Teva Pharms, Mylan, Par Pharm, Parke Davis, Pliva, Purepac Pharm, Roxane, Sandoz, Sun Pharm Industries, Superpharm, Teva, Watson Labs, Dava Pharms Inc, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in ninety-nine NDAs. It is available from ten suppliers. Additional details are available on the METHYLDOPA profile page.

The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.
Summary for 070070
Tradename:METHYLDOPA
Applicant:Accord Hlthcare
Ingredient:methyldopa
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 070070

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength125MG
Approval Date:Oct 15, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
AstraZeneca
Farmers Insurance
Fuji
Healthtrust
Harvard Business School
Cerilliant
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot